Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
typically resolving within 1-2 days of implant placement Expected effects : Skin hyperpigmentation at implant site and systemically (expected pharmacological effect) Melanocytic monitoring : Low rates of new nevi (4% versus 2% placebo in Phase 3)
The Bottom Line Success on GLP-1 medications isn't just about taking your weekly injectionit's about pairing that medication with a strategic nutrition approach that preserves muscle, minimizes side effects, and sets you up for long-term sustainable weight loss
Daley CA, Abbott A, Doyle PS, Nader GA, Larson S
What If: Melanotan-1 Dosage Protocol Scenarios What If I Accidentally Inject 1.5mg Instead of 0.5mg
Even on the lowest dose, patients lost 7.4% of their body weight after just three doses